Holen Sie sich die Stockscreener-App
0.745
1.39%
-0.0054
Envoy Medical Inc Aktie (COCH) Neueste Nachrichten
HC Wainwright Cuts Envoy Medical (NASDAQ:COCH) Price Target to $2.00 - MarketBeat
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com Canada
Envoy (COCH) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Price Move - Vinanet
Envoy (COCH) Q1 2026 Earnings: The Bottom-Line Figure Beats Its Comparison for the Current Session - Vinanet
Envoy (COCHW) Momentum: Trades in a Narrow Directional Range at $0.05 at the Close - Vinanet
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsBullish Percent Index - Vinanet
Price to sales forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street Its The Platformsinvestor distribution. - ACCESS Newswire
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA - Caledonian Record
The Beat: Target names AI chief, Niron gets White House backing, Envoy chases cochlear market - The Business Journals
Envoy Medical Inc. (NASDAQ: COCHW) Stock Price, News & Analysis - Kalkine
Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for Investors - TipRanks
Envoy Medical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Envoy Medical earnings beat, revenue fell short of estimates - Investing.com
Envoy Medical (NASDAQ: COCH) raises cash, advances fully implanted cochlear implant - Stock Titan
Envoy Medical Releases Q2 2026 Financial Results - AlphaStreet
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Envoy Medical Q2 Results: EPS beats estimate, sales miss - scanx.trade
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q Summary - TradingView
Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - Stock Titan
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical (COCH) Reports Q2 2026 Results, Submits First FDA PMA Module and Posts Strong Acclaim® Cochlear Implant Clinical Data - kalkine.ca
Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Envoy Medical (COCH) Holds Near $0.68 as Hearing Implant Developer Digests Post-Listing VolatilityAdvance Decline Line - dars.gov.et
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 3.61% Share GainEarnings Trend Analysis - Vinanet
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCHW - TradingView
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCH - TradingView
Envoy Medical Inc (COCH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Capital Markets initiates Envoy Medical stock with buy rating By Investing.com - Investing.com Canada
Envoy Medical Inc (COCH) Cash Flow - TradingKey
Envoy Medical Inc (COCH) Income Statement - TradingKey
Envoy Medical Inc (COCH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Envoy Medical Warrants Edge Higher Amidst Tight Trading RangeStandard Deviation - dars.gov.et
Envoy Medical Inc (COCH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
COCH Q1 2026 Earnings: Strong EPS Beat Offsets Lack of Reported RevenueGuidance vs Actual - Vinanet
Envoy Medical Inc Warrant (COCHW) Surges 20% Amid Low-Price Volatility – Key Levels to WatchSwing Entry Signals - Vinanet
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo Finance
Envoy Medical (COCH) Projected to Release Quarterly Earnings on Thursday - MarketBeat
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant - Sahm
Exclusive: Envoy Medical builds momentum with improved cochlear implant trial results - MSN
Envoy Medical hits 3-month milestone in trial f... - Pluang
All 56 patients reach 3 months in Envoy Medical's hearing implant trial - Stock Titan
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. I - GuruFocus
Enterprise value to revenue forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN) - New Castle News
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Envoy Medical (COCH) Sheds 7.7% as Stock Tests Key Support at $0.66ETF NAV Deviation - dars.gov.et
Envoy Medical Inc Warrant (COCHW) Surges 36.7%: A Volatile Move Near Key LevelsATR Trailing Stop - dars.gov.et
Frontier tech research, news & data - MLQ.ai
H.C. Wainwright Maintains Envoy Medical(COCH.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo
H.C. Wainwright reiterates Envoy Medical stock rating on trial progress By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Envoy Medical stock rating on trial progress - Investing.com
COCH Reiterated by HC Wainwright & Co. -- Price Target Maintained at $2.50 - GuruFocus
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results - Sahm
Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts - FinancialContent
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant - TMX Newsfile
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group - Newswire.com
Envoy Medical (COCH) Rebounds Sharply: Key Levels and Technical OutlookMFI Oversold - dars.gov.et
COCHEnvoy Medical Inc Earnings - Finviz
0.72%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):